Mark Poritz
Directeur Technique/Scientifique/R&D chez CO-DIAGNOSTICS, INC.
Postes actifs de Mark Poritz
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CO-DIAGNOSTICS, INC. | Directeur Technique/Scientifique/R&D | 01/11/2022 | - |
Historique de carrière de Mark Poritz
Anciens postes connus de Mark Poritz
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Idaho Molecular, Inc.
 Idaho Molecular, Inc. BiotechnologyHealth Technology Part of Co-Diagnostics, Inc., Idaho Molecular, Inc. is a biotechnology company that develops molecular diagnostics test devices. The company is based in South Salt Lake, UT. The CEO of the company is Kirk M. Ririe. Idaho Molecular was acquired by Co-Diagnostics, Inc. on December 31, 2021. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Mark Poritz
| University of California | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CO-DIAGNOSTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Idaho Molecular, Inc.
Idaho Molecular, Inc. BiotechnologyHealth Technology Part of Co-Diagnostics, Inc., Idaho Molecular, Inc. is a biotechnology company that develops molecular diagnostics test devices. The company is based in South Salt Lake, UT. The CEO of the company is Kirk M. Ririe. Idaho Molecular was acquired by Co-Diagnostics, Inc. on December 31, 2021. | Health Technology |
- Bourse
- Insiders
- Mark Poritz
- Expérience